News Image

Which stocks are experiencing notable movement on Wednesday?

By Mill Chart

Last update: Apr 17, 2024

Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.

Gainers

TickerChangeComment
SBFM6.0K%Positive market sentiment drove SUNSHINE BIOPHARMA INC's (NASDAQ:SBFM) stock price up by 6.0K% to $3.95 during Wednesday's session. In the last month the share price increased with 27.1%.
INVO278.0%INVO BIOSCIENCE INC (NASDAQ:INVO) rose 278.0% to $2.87 during Wednesday's after hours session. The stock is trading 25.49% lower than a month ago.
EDBL81.54%Investors celebrated as EDIBLE GARDEN AG INC (NASDAQ:EDBL) experienced a 81.54% rise in its shares, closing at $8.26 during Wednesday's session. A press release (Edible Garden Reports Preliminary First Quarter Year-Over-Year Increase in Produce Revenues of 40%; Cut Herb Revenue Increased More Than 200% for the Same Period) was released earlier today.
SPEC75.08%SPECTAIRE HOLDINGS INC (NASDAQ:SPEC) experienced a significant 75.08% increase, reaching $1.4 during Wednesday's session. A press release (Spectaire Announces Strategic Distribution Partnership with a Fortune 1000 Energy Company) was released earlier today.
BBA.W40.97%BIGBEAR.AI HOLDINGS -CW28 (NYSE:BBA.W) witnessed a notable 40.97% uptick in its shares, reaching $0.31 during Wednesday's session. Shareholders saw the stock price going 45.43% lower in the past month.
VNDA37.9%VANDA PHARMACEUTICALS INC's (NASDAQ:VNDA) shares rose 37.9% to $5.58. In the last year the share price dropped with 36.22%.
VIRX30.86%In an impressive move, VIRACTA THERAPEUTICS INC's (NASDAQ:VIRX) shares recorded a 30.86% increase, closing at $0.94 during Wednesday's session. In the last month the stock lost 27.8%.
GRTX27.71%GALERA THERAPEUTICS INC's (NASDAQ:GRTX) stock price displayed strong growth, advancing 27.71% and reaching $0.22 during Wednesday's session. Shareholders saw the stock price going 29.84% lower in the past month.
SINT24.02%SINTX TECHNOLOGIES INC (NASDAQ:SINT) experienced a significant 24.02% increase, reaching $0.03 during Wednesday's session. Shareholders saw the stock price going 82.01% lower in the past month.
BCAN22.73%Exciting news for BYND CANNASOFT ENTERPRISES (NASDAQ:BCAN) as its stock price surged 22.73% to $1.08 during Wednesday's session. In the last month the stock lost 80.44%.

For the full top gainers list go to our top gainers page.

Top losers

TickerChangeComment
IZM-86.46%During Wednesday's session, ICZOOM GROUP INC -CLASS A's (NASDAQ:IZM) shares took a tumble, falling 86.46% to $6.91. In the last month the stock gained 461.0%.
DARE-41.56%DARE BIOSCIENCE INC's (NASDAQ:DARE) shares fell 41.56% to $0.28 during Wednesday's session. The stock is trading 56.42% higher than 3 months ago.
LGVN-40.51%LONGEVERON INC-A (NASDAQ:LGVN) encountered a 40.51% decrease in its shares, reaching $2.1 during Wednesday's session. In the last 3 months the share price dropped with 62.84%.
TPET-38.55%TRIO PETROLEUM CORP's (NYSEARCA:TPET) shares fell 38.55% to $0.3 during Wednesday's session. In the last month the stock gained 344.0%.
TMQ-37.32%There was a notable decline in TRILOGY METALS INC's (NYSEARCA:TMQ) shares, as they dropped 37.32% to $0.32 during Wednesday's session.
SXTC-25.31%Investors witnessed a 25.31% decrease in CHINA SXT PHARMACEUTICALS IN's (NASDAQ:SXTC) stock price, which closed at $1.21 during Wednesday's session. The stock is trading 42.76% lower than 6 months ago.
ISUN-23.86%During Wednesday's session, ISUN INC's (NASDAQ:ISUN) shares took a tumble, falling 23.86% to $0.16. In the last year the share price dropped with 68.65%.
HUBC-22.04%There was a notable decline in HUB CYBER SECURITY LTD's (NASDAQ:HUBC) shares, as they dropped 22.04% to $1.45 during Wednesday's session. In the last month the stock gained 82.35%.
SAGE-21.24%There was a notable decline in SAGE THERAPEUTICS INC's (NASDAQ:SAGE) shares, as they dropped 21.24% to $12.31 during Wednesday's session. Earlier today the company had a press release: Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease.
OTRK-20.2%There was a downturn in ONTRAK INC's (NASDAQ:OTRK) shares, as they experienced a 20.2% decline, closing at $0.37 during Wednesday's session. A press release (Ontrak Announces 2023 Fourth Quarter and Year End Financial Results) was released yesterday.

Our top losers page will show you the full list.

Back

DARE BIOSCIENCE INC

NASDAQ:DARE (4/29/2024, 7:00:01 PM)

After market: 0.2992 +0.02 (+6.14%)

0.2819

-0.02 (-7.85%)

DARE News

News Image7 days ago - Daré Bioscience, Inc.Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Daré Bioscience’s DARE-LARC1 Platform Technology has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases ...

News Image13 days ago - ChartmillTop movers in Wednesday's session

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

News Image13 days ago - ChartmillWhich stocks are experiencing notable movement on Wednesday?

Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.

News Image19 days ago - Daré Bioscience, Inc.Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive

Published data shows that Ovaprene was safe and effective in a postcoital test study of 33 women Pivotal Phase 3 contraceptive efficacy clinical study of...

News Imagea month ago - InvestorPlaceDARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023

DARE stock results show that Dare Bioscience beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

News Imagea month ago - BusinessInsiderDARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Dare Bioscience (NASDAQ:DARE) just reported results for the fourth quarter of 2...

News Imagea month ago - Daré Bioscience, Inc.Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

Conference Call and Webcast Today at 4:30 p.m. ET...

News Imagea month ago - Daré Bioscience, Inc.Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024

SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will...

News Image3 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!

News Image3 months ago - Daré Bioscience, Inc.Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024

There are no FDA-approved treatments for female sexual arousal disorder...

News Image3 months ago - Seeking AlphaDaré Bioscience announces executive team changes (NASDAQ:DARE)

DARE Bioscience announces retirement of CFO Lisa Walters-Hoffert and resignation of CCO John Fair.

News Image3 months ago - Seeking AlphaDaré Bioscience to eliminate CFO and CCO roles to rein in costs (NASDAQ:DARE)

Daré Bioscience (DARE) said on Friday that co-founder and chief financial information Lisa Walters-Hoffert will retire, effective January 26. The company said

DARE Links
Follow us for more